NIH-funded research R01 grant

Understanding how human antibodies can help develop a vaccine against Staphylococcus aureus

Official title: Interrogating human anti-staphylococcal antibody responses for S. aureus vaccine insights

Funded at University of California, San Diego · NIH-10933027 · Data updated 2026-11-12

This study is looking at how our immune system fights off a common bacteria called Staphylococcus aureus, especially in kids and older adults, to help create a better vaccine by figuring out which antibodies work best against it.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startSeptember 20, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$813,730
NIH project number5R01AI181321-02
Project IDNIH-10933027 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation include children and older adults who have experienced invasive Staphylococcus aureus infections.

Less likely to help

Patients who do not have a history of Staphylococcus aureus infections or are outside the age range of 0-11 years and older adults may not benefit from this research.

What this research studies

This research investigates the immune response to Staphylococcus aureus, a common and dangerous bacteria, particularly in children and older adults. The team will analyze blood samples from these groups to identify which antibodies are effective in fighting this infection. By understanding the differences between protective and non-protective antibodies, the researchers aim to develop a more effective vaccine against Staphylococcus aureus. The study will involve detailed assessments of antibody profiles and their functional capabilities.

Why it matters

Potential benefit: If successful, this research could lead to the development of a vaccine that significantly reduces infections caused by Staphylococcus aureus in vulnerable populations.

How similar studies have gone: While there have been many attempts to create vaccines against Staphylococcus aureus, this approach is novel in its focus on human antibody responses and their implications for vaccine development.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Liu, George Y — University of California, San Diego
  • Study coordinator: Liu, George Y

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.